Brought to you by 
Schering-Plough licenses asthma drugs from Chiroscience
13 Jul 1999
Executive Summary
Schering-Plough has licensed the exclusive, worldwide rights to Chiroscience's PDE IV inhibitors (potential orally-available asthma and other inflammatory disease treatments) for up to $38mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com